Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aging, Immunity, and COVID-19: How Age Influences the Host Immune Response to Coronavirus Infections?
Varnica Bajaj, Nirupa Gadi, Allison P. Spihlman, et al.
Frontiers in Physiology (2021) Vol. 11
Open Access | Times Cited: 433

Showing 1-25 of 433 citing articles:

SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 281
Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
Otávio T. Ranzani, Matt D. T. Hitchings, Murilo Dorión, et al.
BMJ (2021), pp. n2015-n2015
Open Access | Times Cited: 278
Mucosal immune responses to infection and vaccination in the respiratory tract
Robert C. Mettelman, E. Kaitlynn Allen, Paul G. Thomas
Immunity (2022) Vol. 55, Iss. 5, pp. 749-780
Open Access | Times Cited: 153
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection: test negative design study
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, et al.
BMJ (2021), pp. e067873-e067873
Open Access | Times Cited: 151
Efficacy and safety of Paxlovid in severe adult patients with SARS-Cov-2 infection: a multicenter randomized controlled study
Jiao Liu, Xiaojun Pan, Sheng Zhang, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 33, pp. 100694-100694
Open Access | Times Cited: 89
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2–experienced individuals
Marie I. Samanovic, Amber Cornelius, Sophie L. Gray-Gaillard, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 631
Open Access | Times Cited: 87
Advances and gaps in SARS-CoV-2 infection models
César Muñoz‐Fontela, Lina Widerspick, Randy A. Albrecht, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 1, pp. e1010161-e1010161
Open Access | Times Cited: 78
Long COVID: a review and proposed visualization of the complexity of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 62
Association of COVID-19 with Comorbidities: An Update
Sayan Chatterjee, Lakshmi Vineela Nalla, Monika Sharma, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 3, pp. 334-354
Open Access | Times Cited: 56
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 51
Impact of aging on immunity in the context of COVID-19, HIV, and tuberculosis
Alba Grifoni, Tonino Alonzi, Galit Alter, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 50
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
J Ryan Bariola, Erin K McCreary, Richard J. Wadas, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 7
Open Access | Times Cited: 72
Robust immune responses after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals
Marie I. Samanovic, Amber Cornelius, Sophie L. Gray-Gaillard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort
Ariel Israel, Eugene Merzon, Alejandro A. Schäffer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 70
Factors Associated for Mortality of Older People With COVID 19: A Systematic Review and Meta-analysis
H. D. W. T. Damayanthi, K.I.P. Prabani, Ishanka Weerasekara
Gerontology and Geriatric Medicine (2021) Vol. 7
Open Access | Times Cited: 68
Vitamin D and COVID‐19: Role of ACE2, age, gender, and ethnicity
Bruk Getachew, Yousef Tizabi
Journal of Medical Virology (2021) Vol. 93, Iss. 9, pp. 5285-5294
Open Access | Times Cited: 63
TNF‐α/IFN‐γ synergy amplifies senescence‐associated inflammation and SARS‐CoV‐2 receptor expression via hyper‐activated JAK/STAT1
Renuka Kandhaya‐Pillai, Xiaomeng Yang, Tamar Tchkonia, et al.
Aging Cell (2022) Vol. 21, Iss. 6
Open Access | Times Cited: 63
SARS-CoV-2 Infection of Airway Epithelial Cells
Gwanghui Ryu, Hyun‐Woo Shin
Immune Network (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 62
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Seodhna M. Lynch, Guangran Guo, David S. Gibson, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3367-3367
Open Access | Times Cited: 61
Comorbidities and increased mortality of COVID-19 among the elderly: A systematic review
Anna Péterfi, Ágota Mészáros, Z Szarvas, et al.
Physiology International (2022) Vol. 109, Iss. 2, pp. 163-176
Open Access | Times Cited: 57
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world
Vivek P. Chavda, Qian Yao, Lalitkumar K. Vora, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19
Michael E. Bowdish, Christina E. Barkauskas, Jessica Overbey, et al.
American Journal of Respiratory and Critical Care Medicine (2022) Vol. 207, Iss. 3, pp. 261-270
Open Access | Times Cited: 43
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
Vivek P. Chavda, Vasso Apostolopoulos
Maturitas (2022) Vol. 158, pp. 78-81
Open Access | Times Cited: 41
Page 1 - Next Page

Scroll to top